Medicine overcharging claims are raising concerns about price controls in India.
Cancer drug price caps are reshaping investment strategies. Discover why Jefferies favors Fortis, Apollo, and Manipal amidst scrutiny.
Medicine overcharging claims are raising concerns about price controls in India.
Cancer drug price caps are reshaping investment strategies. Discover why Jefferies favors Fortis, Apollo, and Manipal amidst scrutiny.